Eton Pharmaceuticals (ETON) Appoints Judith M. Matthews as New CFO [Yahoo! Finance]
Eton Pharmaceuticals, Inc. (ETON)
Last eton pharmaceuticals, inc. earnings: 3/5 04:02 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
announced a succession plan for its Chief Financial Officer, appointing Judith M. Matthews as Executive Vice President of Accounting and Finance. Matthews is scheduled to officially assume the CFO role on June 1, succeeding James Gruber. To facilitate a smooth leadership transition, Gruber will remain in his current position through May 31 and has committed to a subsequent six-month consulting agreement with the company. Matthews joins the organization with over 25 years of experience in financial leadership within the pharmaceutical and biotechnology sectors. She most recently served as the CFO of Iterum Therapeutics from 2015 to 2026 and previously held the role of Vice President of Finance at Durata Therapeutics. Eton Pharmaceuticals (ETON) Appoints Judith M. Matthews as New CFO CEO Sean Brynjelsen noted that Matthews' expertise in managing growth-focused companies will be vital as Eton enters its next developmental phase. The company remains focused on its mission to build t
Show less
Read more
Impact Snapshot
Event Time:
ETON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ETON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ETON alerts
High impacting Eton Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ETON
News
- Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700GlobeNewswire
- Eton Pharmaceuticals (ETON) was downgraded by Zacks Research from "strong-buy" to "hold".MarketBeat
- How The Hemangeol Deal Is Reframing The Eton Pharmaceuticals (ETON) Investment Story [Yahoo! Finance]Yahoo! Finance
- Eton Pharmaceuticals Announces CFO Succession PlanGlobeNewswire
- How The Eton Pharmaceuticals (ETON) Story Is Shifting With Hemangeol And New Valuation Targets [Yahoo! Finance]Yahoo! Finance
ETON
Earnings
- 3/19/26 - Beat
ETON
Sec Filings
- 4/27/26 - Form 8-K
- 4/24/26 - Form DEF
- 4/22/26 - Form 4
- ETON's page on the SEC website